Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 05-Mar-24 4:20 PM View:  | Alnylam Pharmaceuticals Inc. (ALNY) | 01-Mar-24 | Grant | 23,754 | -- | -- | 49% 48.53K to 72.29K | |
| 29-Feb-24 4:18 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 28-Feb-24 | Option Sale | 2,932 | $155.31 | $455,357.00 | (6%) 51.47K to 48.53K | |
| 29-Feb-24 4:18 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 27-Feb-24 | Option Exercise | 5,921 | -- | -- | 13% 45.55K to 51.47K | |
| 20-Feb-24 4:07 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 16-Feb-24 | Sale | 7,030 | $148.06 | $1,040,880.00 | (13%) 52.58K to 45.55K | |
| 20-Feb-24 4:07 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 15-Feb-24 | Grant | 16,953 | -- | -- | 48% 35.62K to 52.58K | |
| 07-Aug-23 6:04 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 04-Aug-23 | Sale | 4,057 | $185.85 | $753,986.00 | (10%) 39.68K to 35.62K | |
| 07-Aug-23 6:04 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 03-Aug-23 | Grant | 8,941 | -- | -- | 29% 30.74K to 39.68K | |
| 28-Apr-23 5:55 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 27-Apr-23 | Sale | 7,615 | $194.59 | $1,481,810.00 | (20%) 38.35K to 30.74K | |
| 28-Apr-23 5:55 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 26-Apr-23 | Grant | 16,952 | -- | -- | 79% 21.4K to 38.35K | |
| 05-Aug-22 4:13 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 04-Aug-22 | Payment of Exercise | 6,002 | $191.68 | $1,150,440.00 | (22%) 27.4K to 21.4K | |
| 05-Aug-22 4:13 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 03-Aug-22 | Grant | 13,095 | -- | -- | 92% 14.31K to 27.4K | |
| 08-Jun-22 7:26 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 08-Jun-22 | Grant | 1,160 | -- | -- | 10% 12.09K to 13.25K | |
| 23-Dec-21 5:00 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 22-Dec-21 | Payment of Exercise | 2,538 | $189.01 | $479,699.00 | (15%) 16.85K to 14.31K | |
| 23-Dec-21 5:00 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 21-Dec-21 | Grant | 5,417 | -- | -- | 47% 11.43K to 16.85K | |
| 09-Aug-21 4:09 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 06-Aug-21 | Option Exercise | 53,064 | $77.10 | $4,091,230.00 | 464% 11.43K to 64.49K | |
| 09-Aug-21 4:09 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 06-Aug-21 | Market Option Sale (Planned) | 53,064 | $199.00 | $10,559,700.00 | (82%) 64.49K to 11.43K | |
| 11-Jun-21 8:32 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 09-Jun-21 | Grant | 1,066 | -- | -- | 10% 11.02K to 12.09K | |
| 21-Apr-21 6:21 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 20-Apr-21 | Payment of Exercise | 2,351 | $131.85 | $309,977.00 | (17%) 13.78K to 11.43K | |
| 21-Apr-21 6:21 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 19-Apr-21 | Grant | 5,083 | -- | -- | 58% 8.7K to 13.78K | |
| 16-Feb-21 4:07 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 12-Feb-21 | Payment of Exercise | 1,945 | $155.99 | $303,403.00 | (18%) 10.64K to 8.7K | |
| 16-Feb-21 4:07 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 11-Feb-21 | Grant | 5,416 | -- | -- | 104% 5.23K to 10.64K | |
| 13-Jan-21 4:04 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 12-Jan-21 | Option Exercise | 3,125 | $42.22 | $131,938.00 | 60% 5.23K to 8.35K | |
| 13-Jan-21 4:04 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 12-Jan-21 | Market Option Sale (Planned) | 3,125 | $161.00 | $503,125.00 | (37%) 8.35K to 5.23K | |
| 14-Jul-20 4:02 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 10-Jul-20 | Option Exercise | 46,639 | $77.10 | $3,595,870.00 | 892% 5.23K to 51.87K | (8%) |
| 14-Jul-20 4:02 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 10-Jul-20 | Market Option Sale (Planned) | 46,639 | $161.00 | $7,508,880.00 | (90%) 51.87K to 5.23K | |
| 10-Jul-20 4:03 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 09-Jul-20 | Option Exercise | 11,236 | $43.14 | $484,743.00 | 215% 5.23K to 16.46K | |
| 10-Jul-20 4:03 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 09-Jul-20 | Market Option Sale (Planned) | 11,236 | $161.00 | $1,809,000.00 | (68%) 16.46K to 5.23K | |
| 11-Jun-20 6:24 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 09-Jun-20 | Grant | 1,260 | -- | -- | 13% 9.76K to 11.02K | |
| 07-May-20 4:08 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 06-May-20 | Option Exercise | 50,000 | $77.10 | $3,855,000.00 | 957% 5.23K to 55.23K | |
| 07-May-20 4:08 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 06-May-20 | Market Option Sale (Planned) | 50,000 | $150.00 | $7,500,000.00 | (91%) 55.23K to 5.23K | |
| 07-May-20 4:08 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 05-May-20 | Option Exercise | 7,811 | $42.22 | $329,780.00 | 149% 5.23K to 13.04K | |
| 07-May-20 4:08 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 05-May-20 | Market Option Sale (Planned) | 7,811 | $140.00 | $1,093,540.00 | (60%) 13.04K to 5.23K | |
| 09-Apr-20 4:05 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 07-Apr-20 | Grant | 5,417 | -- | -- | 233% 2.32K to 7.74K | |
| 09-Apr-20 4:05 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 07-Apr-20 | Payment of Exercise | 2,513 | $104.86 | $263,503.00 | (32%) 7.74K to 5.23K | |
| 11-Feb-20 4:08 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 10-Feb-20 | Option Exercise | 5,600 | $42.22 | $236,432.00 | 85% 6.62K to 12.21K | |
| 11-Feb-20 4:08 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 10-Feb-20 | Market Option Sale (Planned) | 5,600 | $130.00 | $728,000.00 | (46%) 12.21K to 6.62K | |
| 11-Feb-20 4:08 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 10-Feb-20 | Market Sale (Planned) | 4,292 | $130.00 | $557,960.00 | (65%) 6.62K to 2.32K | |
| 11-Feb-20 4:08 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 07-Feb-20 | Option Exercise | 6,250 | $42.22 | $263,875.00 | 94% 6.62K to 12.87K | |
| 11-Feb-20 4:08 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 07-Feb-20 | Market Option Sale (Planned) | 6,250 | $123.90 | $774,375.00 | (49%) 12.87K to 6.62K | |
| 13-Dec-19 4:25 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 12-Dec-19 | Grant | 7,500 | -- | -- | 323% 2.32K to 9.82K | |
| 13-Dec-19 4:25 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 12-Dec-19 | Payment of Exercise | 3,208 | $120.61 | $386,917.00 | (33%) 9.82K to 6.62K | |
| 22-Nov-19 4:05 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 20-Nov-19 | Option Exercise | 8,404 | $42.22 | $354,817.00 | 362% 2.32K to 10.73K | |
| 22-Nov-19 4:05 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 20-Nov-19 | Market Option Sale (Planned) | 8,404 | $105.00 | $882,420.00 | (78%) 10.73K to 2.32K | |
| 07-Aug-19 4:17 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 11-Jul-19 | Acquisition (other) | 50 | -- | -- | 2% 2.27K to 2.32K | |
| 06-Jun-19 4:36 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 05-Jun-19 | Grant | 4,134 | -- | -- | 73% 5.63K to 9.76K | |
| 07-Jun-19 4:04 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 09-Apr-19 | Acquisition (other) | 49 | -- | -- | 2% 2.22K to 2.27K | |
| 16-Nov-18 5:51 PM View: | Moelis & Co (MC) | 14-Nov-18 | Grant | 34 | -- | -- | 1% 2.89K to 2.92K | |
| 14-Sep-18 6:19 PM View: | Moelis & Co (MC) | 12-Sep-18 | Grant | 112 | -- | -- | 4% 3.13K to 3.24K | |
| 04-Sep-18 4:15 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 30-Aug-18 | Market Sale (Planned) | 2,500 | $120.00 | $300,000.00 | (53%) 4.72K to 2.22K | 30% |
| 14-Aug-18 6:21 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 13-Aug-18 | Grant | 7,500 | -- | -- | 2435% 0.31K to 7.81K |